Predictions
Visiomed Group
Start price
Target price
Perf. (%)
€0.86
25.01.21
25.01.21
€1.00
25.01.22
25.01.22
-80.01%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Crossject S.A.
Start price
Target price
Perf. (%)
€3.67
21.01.21
21.01.21
€10.00
21.01.22
21.01.22
-28.61%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Institut Biophytis Sas
Start price
Target price
Perf. (%)
€1.12
14.12.20
14.12.20
€1.20
14.12.21
14.12.21
-59.19%
15.12.21
15.12.21
Theradiag S.A.
Start price
Target price
Perf. (%)
€2.71
20.11.20
20.11.20
€3.50
20.11.21
20.11.21
-46.16%
21.11.21
21.11.21
Could be worthwhile Investment >10% per year
Theradiag S.A.
Start price
Target price
Perf. (%)
€3.44
06.11.20
06.11.20
€4.50
-21.22%
20.11.20
20.11.20
Could be worthwhile Investment >10% per year
Theranexus
Start price
Target price
Perf. (%)
€11.50
02.11.20
02.11.20
€12.00
04.11.21
04.11.21
-21.57%
11.09.21
11.09.21
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€1.15
31.10.20
31.10.20
€0.000
04.11.21
04.11.21
-33.91%
14.11.20
14.11.20
Safe Orthopaedics S.A.
Start price
Target price
Perf. (%)
€728.90
30.10.20
30.10.20
-
04.11.21
04.11.21
70.56%
15.07.21
15.07.21
Safe Orthopaedics S.A.
Start price
Target price
Perf. (%)
€895.40
28.10.20
28.10.20
-
30.10.20
30.10.20
-18.60%
30.10.20
30.10.20
Safe Orthopaedics S.A.
Start price
Target price
Perf. (%)
€932.40
22.10.20
22.10.20
-
28.10.20
28.10.20
-3.97%
28.10.20
28.10.20
Novacyt S.A.
Start price
Target price
Perf. (%)
€10.10
19.10.20
19.10.20
€4.00
30.10.20
30.10.20
14.26%
30.10.20
30.10.20
Probably not worthwhile Investment
Novacyt S.A.
Start price
Target price
Perf. (%)
€10.10
19.10.20
19.10.20
-
04.11.21
04.11.21
-72.31%
05.11.21
05.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group